Is Cynata Therapeutics Limited (CYYNF) a Buy, Sell, or Hold?
OTC : CYYNF
Cynata Therapeutics Limited — News
$0.004 USD
$0 (0.0%)
- Volume
- 220
- Average Volume
- 199
- Market Capitalization
- $973.82K
- P/E Ratio
- -0.30
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.22
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.49
| Source | Headline |
|---|---|
|
Cynata Therapeutics Limited (CYYNF) Discusses Phase II Acute Graft Versus Host Disease and Phase III Osteoarthritis Trial Results Transcript
Cynata Therapeutics Limited (CYYNF) Discusses Phase II Acute Graft Versus Host Disease and Phase III Osteoarthritis Trial Results Transcript seekingalpha.com - 2026-06-21 22:12:08 |
